| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.29 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |